We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAL
1676
DELISTED
Salisbury Bancorp, Inc.
SAL
$22K ﹤0.01%
1,000
– –
CATM
1677
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$22K ﹤0.01%
534
-138
-21% -$5.24K
HCBC
1678
DELISTED
HIGH COUNTRY BANCORP INC
HCBC
$22K ﹤0.01%
500
– –
CEO
1679
DELISTED
CNOOC Limited
CEO
$22K ﹤0.01%
133
-100
-43% -$15.3K
ALB icon
1680
Albemarle
ALB
$13.4B
$21K ﹤0.01%
291
-11,801
-98% -$788K
ALNY icon
1681
Alnylam Pharmaceuticals
ALNY
$38.1B
$21K ﹤0.01%
185
– –
AROC icon
1682
Archrock
AROC
$6.16B
$21K ﹤0.01%
2,108
+374
+22% +$3.49K
BLMN icon
1683
Bloomin' Brands
BLMN
$753M
$21K ﹤0.01%
995
+99
+11% +$2.1K
EPAC icon
1684
Enerpac Tool Group
EPAC
$1.84B
$21K ﹤0.01%
816
+279
+52% +$6.81K
EWH icon
1685
iShares MSCI Hong Kong ETF
EWH
$1.23B
$21K ﹤0.01%
866
– –
FUL icon
1686
H.B. Fuller
FUL
$2.99B
$21K ﹤0.01%
418
+172
+70% +$8.52K
IUSG icon
1687
iShares Core S&P US Growth ETF
IUSG
$30.6B
$21K ﹤0.01%
325
– –
JBGS
1688
JBG SMITH
JBGS
$857M
$21K ﹤0.01%
550
-100
-15% -$3.96K
KNOP icon
1689
KNOT Offshore Partners
KNOP
$350M
$21K ﹤0.01%
1,100
– –
PSCH icon
1690
Invesco S&P SmallCap Health Care ETF
PSCH
$162M
$21K ﹤0.01%
+489
New +$19.8K
RGNX icon
1691
Regenxbio
RGNX
$613M
$21K ﹤0.01%
545
+332
+156% +$13.1K
RMBS icon
1692
Rambus
RMBS
$9.03B
$21K ﹤0.01%
1,578
+947
+150% +$12.7K
RYN icon
1693
Rayonier
RYN
$6.6B
$21K ﹤0.01%
716
– –
SBRA icon
1694
Sabra Healthcare REIT
SBRA
$5.58B
$21K ﹤0.01%
985
– –
STM icon
1695
STMicroelectronics
STM
$43.1B
$21K ﹤0.01%
783
-235
-23% -$5.56K
WING icon
1696
Wingstop
WING
$3.86B
$21K ﹤0.01%
252
+99
+65% +$8.22K
KAMN
1697
DELISTED
Kaman Corp
KAMN
$21K ﹤0.01%
329
+148
+82% +$9.24K
POLY
1698
DELISTED
Plantronics, Inc.
POLY
$21K ﹤0.01%
771
– –
TECD
1699
DELISTED
Tech Data Corp
TECD
$21K ﹤0.01%
151
-42,715
-100% -$5.49M
AA icon
1700
Alcoa
AA
$11.3B
$20K ﹤0.01%
976
-48,427
-98% -$1M
66 67
68
69 70

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.